Oncogenic c-H-ras deregulates survivin expression: An improvement for survival

FEBS Letters

Volumn 581, Issue 25, 2007, Pages 4921-4926

  Sommer, Klaus W ^a,c   Rodgarkia Dara, Chantal J ^a   Schreiner, Claudia ^a,d   Holzmann, Klaus ^a   Krupitza, Georg ^b   Cerni, Christa ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c JOHANNES KEPLER UNIVERSITY LINZ   (Austria)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

c H ras; Cell cycle; Chemotherapy; Drug induced apoptosis; HeLa; Survivin

Indexed keywords

SURVIVIN;

APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL CYCLE G2 PHASE; CELL CYCLE PHASE; CELL LINE; CELL PROTECTION; CONTROLLED STUDY; DEREGULATION; HELA CELL; HUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; CELL CYCLE; DOXORUBICIN; HELA CELLS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; ONCOGENE PROTEIN P21(RAS); RNA INTERFERENCE;

EID: 34948851397     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.09.023     Document Type: Article

References (44)

1. Rosa J., Canovas P., Islam A., Altieri D.C., and Doxsey S.J. Survivin modulates microtubule dynamics and nucleation throughout the cell cycle. Mol. Biol. Cell 17 (2006) 1483-1493
2. Altieri D.C. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr. Opin. Cell Biol. 18 (2006) 609-615
3. Wheatley S.P., Henzing A.J., Dodson H., Khaled W., and Earnshaw W.C. Aurora-B phosphorylation in vitro identifies a residue of survivin that is essential for its localization and binding to inner centromere protein (INCENP) in vivo. J. Biol. Chem. 279 (2004) 5655-5660
4. Vong Q.P., Cao K., Li H.Y., Iglesias P.A., and Zheng Y. Chromosome alignment and segregation regulated by ubiquitination of survivin. Science 310 (2005) 1499-1504
5. Honda R., Korner R., and Nigg E.A. Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis. Mol. Biol. Cell 14 (2003) 3325-3341
6. Li F., and Ling X. Survivin study: an update of "what is the next wave"?. J. Cell. Physiol. 208 (2006) 476-486
7. Dohi T., Beltrami E., Wall N.R., Plescia J., and Altieri D.C. Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. J. Clin. Invest. 114 (2004) 1117-1127
8. Altieri D.C. Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm. J. Cell. Biochem. 92 (2004) 656-663
9. Altieri D.C. Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 3 (2003) 46-54
10. Zaffaroni N., Pennati M., and Daidone M.G. Survivin as a target for new anticancer interventions. J. Cell. Mol. Med. 9 (2005) 360-372
11. Ambrosini G., Adida C., and Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3 (1997) 917-921
12. Uren A.G., Wong L., Pakusch M., Fowler K.J., Burrows F.J., Vaux D.L., and Choo K.H. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr. Biol. 10 (2000) 1319-1328
13. Fukuda S., and Pelus L.M. Survivin, a cancer target with an emerging role in normal adult tissues. Mol. Cancer Ther. 5 (2006) 1087-1098
14. Adida C., et al. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 96 (2000) 1921-1925
15. Martinez A., et al. Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival. Am. J. Pathol. 164 (2004) 501-510
16. Kawasaki H., et al. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer 91 (2001) 2026-2032
17. Takai N., Miyazaki T., Nishida M., Nasu K., and Miyakawa I. Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma. Cancer Lett. 184 (2002) 105-116
18. Li F., and Brattain M.G. Role of the Survivin gene in pathophysiology. Am. J. Pathol. 169 (2006) 1-11
19. Adjei A.A. Blocking oncogenic Ras signaling for cancer therapy. J. Natl. Cancer Inst. 93 (2001) 1062-1074
20. Fukuda S., and Pelus L.M. Activated H-Ras regulates hematopoietic cell survival by modulating survivin. Biochem. Biophys. Res. Commun. 323 (2004) 636-644
21. Sommer K.W., Schamberger C.J., Schmidt G.E., Sasgary S., and Cerni C. Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras. Oncogene 22 (2003) 4266-4280
22. Wheatley S.P., and McNeish I.A. Survivin: a protein with dual roles in mitosis and apoptosis. Int. Rev. Cytol. 247 (2005) 35-88
23. Li F., and Altieri D.C. Transcriptional analysis of human survivin gene expression. Biochem. J. 344 Pt 2 (1999) 305-311
24. Zhao J., Tenev T., Martins L.M., Downward J., and Lemoine N.R. The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J. Cell Sci. 113 Pt 23 (2000) 4363-4371
25. Fortugno P., et al. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J. Cell Sci. 115 (2002) 575-585
26. Shin S., et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40 (2001) 1117-1123
27. Salvesen G.S., and Duckett C.S. IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell. Biol. 3 (2002) 401-410
28. Liu T., Brouha B., and Grossman D. Rapid induction of mitochondrial events and caspase-independent apoptosis in survivin-targeted melanoma cells. Oncogene 23 (2004) 39-48
29. Chakravarti A., et al. Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. Oncogene 23 (2004) 7494-7506
30. Kim P.J., Plescia J., Clevers H., Fearon E.R., and Altieri D.C. Survivin and molecular pathogenesis of colorectal cancer. Lancet 362 (2003) 205-209
31. Song J., So T., Cheng M., Tang X., and Croft M. Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion. Immunity 22 (2005) 621-631
32. Jaggi R., Salmons B., Muellener D., and Groner B. The v-mos and H-ras oncogene expression represses glucocorticoid hormone-dependent transcription from the mouse mammary tumor virus LTR. Embo J. 5 (1986) 2609-2616
33. Cerni C., Skrzypek B., Popov N., Sasgary S., Schmidt G., Larsson L.G., Luscher B., and Henriksson M. Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1. Oncogene 21 (2002) 447-459
34. Katz M.E., and McCormick F. Signal transduction from multiple Ras effectors. Curr. Opin. Genet. Dev. 7 (1997) 75-79
35. Ling X., and Li F. Silencing of antiapoptotic survivin gene by multiple approaches of RNA interference technology. Biotechniques 36 (2004) 450-454 456-460
36. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., and Altieri D.C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396 (1998) 580-584
37. Altieri D.C. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol. Med. 7 (2001) 542-547
38. Bao R., Connolly D.C., Murphy M., Green J., Weinstein J.K., Pisarcik D.A., and Hamilton T.C. Activation of cancer-specific gene expression by the survivin promoter. J. Natl. Cancer Inst. 94 (2002) 522-528
39. Grossman D., McNiff J.M., Li F., and Altieri D.C. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J. Invest. Dermatol. 113 (1999) 1076-1081
40. Fukuda S., Foster R.G., Porter S.B., and Pelus L.M. The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. Blood 100 (2002) 2463-2471
41. Zhang M., Latham D.E., Delaney M.A., and Chakravarti A. Survivin mediates resistance to antiandrogen therapy in prostate cancer. Oncogene 24 (2005) 2474-2482
42. Suzuki A., Hayashida M., Ito T., Kawano H., Nakano T., Miura M., Akahane K., and Shiraki K. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. Oncogene 19 (2000) 3225-3234
43. Jiang Y., Saavedra H.I., Holloway M.P., Leone G., and Altura R.A. Aberrant regulation of survivin by the RB/E2F family of proteins. J. Biol. Chem. 279 (2004) 40511-40520
44. Altieri D.C. T cell expansion: the survivin interface between cell proliferation and cell death. Immunity 22 (2005) 534-535